Source: Annual Congress 2006 - Pulmonary arterial hypertension: from bench back to bedside
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Sitbon, C. Lascoux-Combe, D. Sereni, F. Raffi, P. Yeni, V. Gressin, P. Clerson, J. F. Delfraissy, G. Simonneau (Clamart, Paris, Nantes, Roubaix, Le Kremlin Bicetre, France). Prevalence of pulmonary arterial hypertension in HIV positive outpatients in the HAART era. Eur Respir J 2006; 28: Suppl. 50, 3147

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary arterial hypertension in patients with HIV infection Source: Eur Respir Mon 2012; 57: 82-93 Year: 2012 Pulmonary arterial hypertension associated to HIV infection Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Bosentan in pulmonary arterial hypertension associated with HIV infection Source: Eur Respir J 2003; 22: Suppl. 45, 563s Year: 2003 Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy Source: Eur Respir J 2009; 34: 277-278 Year: 2009 Prevalence of pulmonary hypertension in patients undergo hemodialysis Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension Source: ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020 Year: 2020 Prevalence of pulmonary hypertension in patients after splenectomy Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008 Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era Source: Eur Respir J, 51 (6) 1800307; 10.1183/13993003.00307-2018 Year: 2018 Unique hemodynamic profile of HIV patients with portal hypertension: Comparison with HIV-associated PAH and porto-pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Current medical treatment of pulmonary arterial hypertension Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Current medical treatment of pulmonary arterial hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Current medical treatment of pulmonary arterial hypertension Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Current medical treatment of pulmonary arterial hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 The prevalence of pulmonary hypertension and the related factors in hemodialysis patients Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 How to manage patients with arterial hypertension in the era of COVID-19 Source: COVID-19 Videos Year: 2020 Pulmonary arterial hypertension: tailoring treatment to risk in the current era Source: Eur Respir Rev, 26 (146) 170095; 10.1183/16000617.0095-2017 Year: 2017